Literature DB >> 24189146

Restricted expression of miR-30c-2-3p and miR-30a-3p in clear cell renal cell carcinomas enhances HIF2α activity.

Lijoy K Mathew1, Samuel S Lee, Nicolas Skuli, Shilpa Rao, Brian Keith, Katherine L Nathanson, Priti Lal, M Celeste Simon.   

Abstract

Inactivation of the von-Hippel Lindau (VHL) tumor suppressor gene occurs in 90% of human clear cell renal cell carcinomas (ccRCC) and leads to the stable expression of the hypoxia-inducible factors HIF1α and HIF2α. The constitutive expression of HIF1α in a majority of VHL-deficient tumors is counterintuitive, given that HIF1α functions as a tumor suppressor in ccRCC, whereas HIF2α clearly enhances tumor growth. We demonstrate here that miR-30c-2-3p and miR-30a-3p specifically bind and inhibit expression of HIF2A transcripts, and that the locus encoding miR-30c-2-3p and miR-30a-3p is selectively repressed in "H1H2" VHL-deficient tumors expressing both HIF1α and HIF2α proteins. Inhibiting miR-30a-3p expression increases HIF2α levels in H1H2 ccRCC cells and promotes cellular proliferation, angiogenesis, and xenograft tumor growth. Our results indicate that miR-30c-2-3p and miR-30a-3p repression enhances HIF2α expression and suggests a mechanism whereby the tumor-suppressive effects of constitutive HIF1α expression are attenuated in VHL-deficient H1H2 tumors.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24189146      PMCID: PMC3947282          DOI: 10.1158/2159-8290.CD-13-0291

Source DB:  PubMed          Journal:  Cancer Discov        ISSN: 2159-8274            Impact factor:   39.397


  25 in total

1.  Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma.

Authors:  Raju R Raval; Kah Weng Lau; Maxine G B Tran; Heidi M Sowter; Stefano J Mandriota; Ji-Liang Li; Christopher W Pugh; Patrick H Maxwell; Adrian L Harris; Peter J Ratcliffe
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

Review 2.  Diagnostic, prognostic and therapeutic implications of microRNAs in urologic tumors.

Authors:  Annika Schaefer; Carsten Stephan; Jonas Busch; George M Yousef; Klaus Jung
Journal:  Nat Rev Urol       Date:  2010-04-06       Impact factor: 14.432

3.  RACK1 competes with HSP90 for binding to HIF-1alpha and is required for O(2)-independent and HSP90 inhibitor-induced degradation of HIF-1alpha.

Authors:  Ye V Liu; Jin H Baek; Huafeng Zhang; Roberto Diez; Robert N Cole; Gregg L Semenza
Journal:  Mol Cell       Date:  2007-01-26       Impact factor: 17.970

Review 4.  Treatment of kidney cancer: insights provided by the VHL tumor-suppressor protein.

Authors:  William G Kaelin
Journal:  Cancer       Date:  2009-05-15       Impact factor: 6.860

Review 5.  Oncogenic role of microRNAs in brain tumors.

Authors:  Jesse Chung-sean Pang; Wai Kei Kwok; Zhongping Chen; Ho-Keung Ng
Journal:  Acta Neuropathol       Date:  2009-04-03       Impact factor: 17.088

6.  HIF-alpha effects on c-Myc distinguish two subtypes of sporadic VHL-deficient clear cell renal carcinoma.

Authors:  John D Gordan; Priti Lal; Vijay R Dondeti; Richard Letrero; Krishna N Parekh; C Elisa Oquendo; Roger A Greenberg; Keith T Flaherty; W Kimryn Rathmell; Brian Keith; M Celeste Simon; Katherine L Nathanson
Journal:  Cancer Cell       Date:  2008-12-09       Impact factor: 31.743

7.  pVHL acts as an adaptor to promote the inhibitory phosphorylation of the NF-kappaB agonist Card9 by CK2.

Authors:  Haifeng Yang; Yoji Andrew Minamishima; Qin Yan; Susanne Schlisio; Benjamin L Ebert; Xiaoping Zhang; Liang Zhang; William Y Kim; Aria F Olumi; William G Kaelin
Journal:  Mol Cell       Date:  2007-10-12       Impact factor: 17.970

8.  Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model.

Authors:  Janaiah Kota; Raghu R Chivukula; Kathryn A O'Donnell; Erik A Wentzel; Chrystal L Montgomery; Hun-Way Hwang; Tsung-Cheng Chang; Perumal Vivekanandan; Michael Torbenson; K Reed Clark; Jerry R Mendell; Joshua T Mendell
Journal:  Cell       Date:  2009-06-12       Impact factor: 41.582

9.  Inhibition of HIF2alpha is sufficient to suppress pVHL-defective tumor growth.

Authors:  Keiichi Kondo; William Y Kim; Mirna Lechpammer; William G Kaelin
Journal:  PLoS Biol       Date:  2003-12-22       Impact factor: 8.029

Review 10.  Hypoxia response and microRNAs: no longer two separate worlds.

Authors:  Mircea Ivan; Adrian L Harris; Fabio Martelli; Ritu Kulshreshtha
Journal:  J Cell Mol Med       Date:  2008-07-08       Impact factor: 5.310

View more
  32 in total

Review 1.  The EGLN-HIF O2-Sensing System: Multiple Inputs and Feedbacks.

Authors:  Mircea Ivan; William G Kaelin
Journal:  Mol Cell       Date:  2017-06-15       Impact factor: 17.970

Review 2.  The epigenetic landscape of renal cancer.

Authors:  Mark R Morris; Farida Latif
Journal:  Nat Rev Nephrol       Date:  2016-11-28       Impact factor: 28.314

3.  MicroRNA-30c-2-3p negatively regulates NF-κB signaling and cell cycle progression through downregulation of TRADD and CCNE1 in breast cancer.

Authors:  Kirti Shukla; Ashwini Kumar Sharma; Aoife Ward; Rainer Will; Thomas Hielscher; Aleksandra Balwierz; Christian Breunig; Ewald Münstermann; Rainer König; Ioanna Keklikoglou; Stefan Wiemann
Journal:  Mol Oncol       Date:  2015-02-10       Impact factor: 6.603

4.  Association between polymorphisms in the integrin gene predicted microRNA binding sites and bladder cancer risk.

Authors:  Jiaming Liu; Sihang Cheng; Yonggang Zhang; Hong Li; Jin Huang; Peng Zhang
Journal:  Int J Clin Exp Med       Date:  2014-11-15

Review 5.  The tumor microenvironment in renal cell cancer.

Authors:  James W Mier
Journal:  Curr Opin Oncol       Date:  2019-05       Impact factor: 3.645

6.  Characterization of the microRNA transcriptomes and proteomics of cochlear tissue-derived small extracellular vesicles from mice of different ages after birth.

Authors:  Pei Jiang; Xiangyu Ma; Shanying Han; Leyao Ma; Jingru Ai; Leilei Wu; Yuan Zhang; Hairong Xiao; Mengyao Tian; W Andy Tao; Shasha Zhang; Renjie Chai
Journal:  Cell Mol Life Sci       Date:  2022-02-26       Impact factor: 9.261

Review 7.  The effect of HIF on metabolism and immunity.

Authors:  Cormac T Taylor; Carsten C Scholz
Journal:  Nat Rev Nephrol       Date:  2022-06-20       Impact factor: 42.439

8.  Methylation and expression levels of microRNA-23b/-24-1/-27b, microRNA-30c-1/-30e, microRNA-301a and let-7g are dysregulated in clear cell renal cell carcinoma.

Authors:  I Gilyazova; E Ivanova; G Gilyazova; I Sultanov; A Izmailov; R Safiullin; V Pavlov; E Khusnutdinova
Journal:  Mol Biol Rep       Date:  2021-07-24       Impact factor: 2.316

9.  CircRNA-23525 regulates osteogenic differentiation of adipose-derived mesenchymal stem cells via miR-30a-3p.

Authors:  Zeyou Guo; Luyang Zhao; Suhui Ji; Ting Long; Yanling Huang; Rui Ju; Wei Tang; Weidong Tian; Jie Long
Journal:  Cell Tissue Res       Date:  2020-11-05       Impact factor: 5.249

10.  Lysophosphatidic Acid Mediates Activating Transcription Factor 3 Expression Which Is a Target for Post-Transcriptional Silencing by miR-30c-2-3p.

Authors:  Ha T Nguyen; Wei Jia; Aaron M Beedle; Eileen J Kennedy; Mandi M Murph
Journal:  PLoS One       Date:  2015-09-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.